Tag Archives: Neuroscience

Of Mice And Men: Translation In Psychiatric Disease
May 12, 2016

This blog was written by Vanessa King, CEO of Luc Therapeutics, as part of the From The Trenches feature of LifeSciVC Almost 15 years ago – in 2003, to be precise – I was working with genome sequencing pioneer Craig

2 Comments

Are We Poised for a Neuroscience Research Renaissance?  Maybe
February 9, 2016

This blog was written by Adam Rosenberg, CEO of Rodin Therapeutics, as part of the From The Trenches feature of LifeSciVC. After a long, challenging period for CNS R&D – marked by late-stage clinical failures, mass layoffs, and limited early-stage

3 Comments

Follow The Patients: The Case For Neuroscience And Other “Challenging” Fields
September 11, 2014

This blog was written by Ankit Mahadevia, CBO of Rodin Therapeutics and Spero Therapeutics, as part of the “From the Trenches” feature of LifeSciVC. There’s an ebb and flow in our business around interest in specific therapeutic areas; hot TAs such

Leave a comment